Study explores whole-body immunity

November 21, 2017 by Peter Reuell, Harvard University
Credit: CC0 Public Domain

Over the next few months, millions of people will receive vaccinations in the hope of staving off the flu—and the fever, pain, and congestion that come with it.

But how can one injection trigger an that protects someone from head to toe?

Part of the answer, says Nicolas Chevrier, a former Bauer Fellow at the Harvard FAS Center for Systems Biology and now an assistant professor in molecular engineering at the University of Chicago, appears to lie in the way antiviral signals spread through the body within hours of a vaccination, seeding in various tissues. Chevrier's findings are described in an Oct. 5 paper published in Cell.

"The starting point for this study was the question of how do we study the at the scale of the whole organism?" Chevrier said. "Immune cells are in every organ of the body—in the lungs, the heart, the skin—making it incredibly challenging to study how the immune system can operate across the entire organism. Current studies are siloed. For example, people only looked at the lungs or only looked at the blood."

To find answers, Chevrier and colleagues turned to a pair of Vaccinia viruses—one a pathogenic version of the disease and the other an inactive strain deployed for formulating vaccines similar to those used to eradicate smallpox in the early 20th century.

"To test our idea, we wanted something to trigger and compare various types of immune responses from vaccination alone, to infection alone, and to a protective one [infection of vaccinated individuals]," he said. "Using this comparative approach allowed us to ask: When you immunize at the skin, does the response stay localized, or does it become systemic? And if so, how far and how fast does it spread? These are fundamental questions about the inner working of the immune system at a scale that we didn't have any way to look at."

Researchers first immunized mice against the disease to study how their immune systems responded to the vaccine, and later exposed the same mice to the pathogenic version of the virus to study how it triggered their immune defenses.

"We were very excited to see that our approach worked," Chevrier said. "We could observe and track immune processes at the whole-body scale for the first time. Based on these findings, we uncovered two new mechanisms of critical for the host. First, we found that within hours of being vaccinated, a whole-body antiviral is created—as if the body's defenses were anticipating its virus opponent's next moves to win the battle."

That process, he explained, involves a molecule known as interferon, which is secreted at the point of immunization, and quickly propagates through most tissues via the bloodstream.

For years, Chevrier said, scientists believed interferon was merely a local response to an immune trigger, but the new study suggests that it may actually play an important role in activating antiviral genes across many tissues, helping them fight off infection.

What Chevrier dubbed the protective response, on the contrary, seems far more localized to a few organs.

"It seems to be more restrained to where the virus goes," he said. "In our tests, the infection came in through the lungs, and very quickly progressed to the liver and the spleen. But the immune defenses set by vaccination stopped the virus right there, and very efficiently. We found that memory cells are instructed to reside in those tissues and are set up to counter a potential reinfection."

That finding contradicts accepted wisdom, which had been that those cells could most effectively fight infection by circulating through the body. In recent years, however, evidence has emerged suggesting that the resident cells might be more potent and widespread than first thought.

"They were seen as local protectors," Chevrier said. "People thought that when you got immunized at the skin, for example, those cells would reside in the skin, but what we've found is that they're seeded much more broadly across the body to serve as systemic protectors. So as soon as the virus arrives in the liver or the spleen, those are ideally placed to fight off the infection as it unfolds."

He added: "Our study is a proof of principle that the immune system can be observed and studied at the whole-body scale in mammals—as opposed to one or few tissues at a time. That being said, much effort is now needed to test this idea in other immune processes linked to health and disease."

Explore further: Zika-related nerve damage caused by immune response to the virus

More information: Motohiko Kadoki et al. Organism-Level Analysis of Vaccination Reveals Networks of Protection across Tissues, Cell (2017). DOI: 10.1016/j.cell.2017.08.024

Related Stories

Zika-related nerve damage caused by immune response to the virus

November 20, 2017
The immune system's response to the Zika virus, rather than the virus itself, may be responsible for nerve-related complications of infection, according to a Yale study. This insight could lead to new ways of treating patients ...

New knowledge on how HIV beats the body's early immune response

September 14, 2017
In an important step towards eradicating HIV-associated viral reservoirs, researchers at Sydney's Westmead Institute for Medical Research have identified how the HIV virus hijacks the innate immune system to facilitate its ...

Scientists find potential mechanism for deadly, sepsis-induced secondary infection

September 14, 2017
In mice, an infection-induced condition known as sepsis may increase the risk of life-threatening secondary infection by preventing recruitment of infection-fighting cells to the skin, according to new research published ...

Blood-filtering organs fight infections that enter through the skin

August 16, 2017
New information about how and where the innate immune system fights off viral infections that enter through the skin could lead to better treatments for viruses like Zika, dengue and measles, according to Penn State College ...

Mouse model could shed new light on immune system response to Zika virus

February 23, 2017
A new mouse model with a working immune system could be used in laboratory research to improve understanding of Zika virus infection and aid development of new treatments, according to a study published in PLOS Pathogens.

Recommended for you

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

New immunotherapy targeting blood-clotting protein

October 15, 2018
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Immune health maintained by meticulously ordered DNA

October 15, 2018
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organisation skills of a protein called Pax5.

Enzyme that triggers autoimmune responses from T-cells in patients with MS found

October 11, 2018
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.